Try our mobile app

Published: 2021-02-17 06:06:35 ET
<<<  go to IBN company page
6-K 1 dp146161_6k-2.htm FORM 6-K

FORM 6-K

 

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

Report of Foreign Issuer

 

Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934

 

For the month February, 2021

Commission File Number: 001-15002

 

ICICI Bank Limited
(Translation of registrant’s name into English)

 

ICICI Bank Towers,
Bandra-Kurla Complex
Mumbai, India 400 051
(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file
annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F   X    Form 40-F      

 

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1):

 

Yes          No   X 

 

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7):

 

Yes         No   X 

 

Indicate by check mark whether by furnishing the information
contained in this Form, the Registrant is also thereby furnishing the
information to the Commission pursuant to Rule 12g3-2(b)
under the Securities Exchange Act of 1934:

 

Yes         No   X 

 

If “Yes” is marked, indicate below the file number assigned to the registrant in
connection with Rule 12g 3-2(b): Not Applicable

 

 

 

Table of Contents

 

Item  
   

1.

 

Other news

 

 

 

 

 

 

OTHER NEWS

 

Subject: Disclosure under Indian Listing Regulations

 

IBN 

ICICI Bank Limited (the ‘Bank’) Report on Form 6-K

 

The Bank has made the below announcement to the Indian stock exchanges:

 

We wish to inform you that ICICI Bank Limited has entered into an agreement dated February 16, 2021 in relation to an Investment in the equity shares and compulsorily convertible preference shares (“CCPS”) of Thillais Analytical Solutions Private Limited.

 

Pursuant to Regulation 30 read with para A of part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, as amended read with SEBI circular no. CIR/CFD/CMD/4/2015 dated September 9, 2015, we wish to provide the following disclosure:

 

a. Name of the target entity, details in brief such as size, turnover etc.

Thillais Analytical Solutions Private Limited 

Turnover (FY21 Estimated): 1.1 million 

PAT (FY 21 Estimated): Loss of 2.1 million 

b. Whether the acquisition would fall within related party transaction(s) and whether the promoter/ promoter group/ group companies have any interest in the entity being acquired? If yes, nature of interest and details thereof and whether the same is done at “arm’s length”

This transaction does not constitute a related party transaction. ICICI Bank Limited has no promoters.

 

ICICI Bank Limited and its subsidiaries in the normal course of business would have business dealings with Thillais Analytical Solutions Private Limited at an arm’s length. 

c. Industry to which the entity being acquired belongs Thillais Analytical Solutions Private Limited is a fintech startup which operates a neo-banking platform ‘Vanghee’ which facilitates connected banking solutions for corporates and MSMEs and helps banks deepen their customer relationships.
d. Objects and effects of acquisition (including but not limited to, disclosure of reasons for acquisition of target entity, if its business is outside the main line of business of the listed entity) Financial Investment

 

 

 

   

 

 

e. Brief details of any governmental or regulatory approvals required for the acquisition Since the acquisition of shareholding is below 10%, regulatory approval is not required.
f. Indicative time period for completion of the acquisition End of March 2021
g. Nature of consideration - whether cash consideration or share swap and details of the same Cash consideration of ₹ 11 million
h. Cost of acquisition or the price at which the shares are acquired Cash consideration of 11 million for 9.65% shareholding of Thillais Analytical Solutions Private Limited.
i. Percentage of shareholding / control acquired and / or number of shares acquired

Post investment, ICICI Bank Limited will hold 9.65% shareholding (on a fully diluted basis) in Thillais Analytical Solutions Private Limited through acquisition of 10 equity shares and 100 CCPS.

 

j. Brief background about the entity acquired in terms of products/line of business acquired, date of incorporation, history of last 3 years turnover, country in which the acquired entity has presence and any other significant information (in brief)

Date of Incorporation: October 23, 2020

 

Products/Line of business: Thillais Analytical Solutions Private Limited is a fintech startup which operates a neo-banking platform ‘Vanghee’ which facilitates connected banking for corporates and MSMEs and helps banks deepen their customer relationships.

 

History of last 3 years turnover: Not applicable since the entity was incorporated in October 2020.

 

Country of presence: India 

 

You are requested to please take the above information on record.

 

 

ICICI Bank Limited

ICICI Bank Towers 

Bandra-Kurla Complex 

Mumbai 400 051, India. 

Tel.: (91-22) 2653 1414 

Fax: (91-22) 2653 1122 

Website www.icicibank.com 

CIN.: L65190GJ1994PLC021012 

Regd. Office: ICICI Bank Tower, 

Near Chakli Circle, 

Old Padra Road 

Vadodara 390007. India 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.

 

     

For ICICI Bank Limited

 

Date: February 16, 2021   By:               /s/s/Vivek Ranjan
        Name :      Vivek Ranjan
        Title   :    Chief Manager